The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

por Al-Saad, S, Al-Shibli, K, Donnem, T, Persson, M, Bremnes, R M, Busund, L-T
Publicado 2008

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung...

por Strøm, H H, Bremnes, R M, Sundstrøm, S H, Helbekkmo, N, Fløtten, Ø, Aasebø, U
Publicado 2013

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer

por Brydøy, M, Fosså, S D, Klepp, O, Bremnes, R M, Wist, E A, Bjøro, T, Wentzel-Larsen, T, Dahl, O
Publicado 2012

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

por von Plessen, C, Bergman, B, Andresen, O, Bremnes, R M, Sundstrom, S, Gilleryd, M, Stephens, R, Vilsvik, J, Aasebo, U, Sorenson, S
Publicado 2006

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Gro...

por Fløtten, Ø, Grønberg, B H, Bremnes, R, Amundsen, T, Sundstrøm, S, Rolke, H, Hornslien, K, Wentzel-Larsen, T, Aasebø, U, von Plessen, C
Publicado 2012

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

por Helbekkmo, N, Sundstrøm, S H, Aasebø, U, Fr Brunsvig, P, von Plessen, C, Hjelde, H H, Garpestad, O K, Bailey, A, Bremnes, R M
Publicado 2007

High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients

por Stoen, Maria Jenvin, Andersen, S., Rakaee, M., Pedersen, M. I., Ingebriktsen, L. M., Bremnes, R. M., Donnem, T., Lombardi, A. P. G., Kilvaer, T. K., Busund, L. T., Richardsen, E.
Publicado 2021

High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival

por Helland, Å., Brustugun, O. T., Nakken, S., Halvorsen, A. R., Dønnem, T., Bremnes, R., Busund, L. T., Sun, J., Lorenz, S., Solberg, S. K., Jørgensen, L. H., Vodak, D., Myklebost, O., Hovig, E., Meza‐Zepeda, L. A.
Publicado 2017

Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer

por Richardsen, E., Andersen, S., Al-Saad, S., Rakaee, M., Nordby, Y., Pedersen, M. I., Ness, N., Ingebriktsen, L. M., Fassina, A., Taskén, K. A., Mills, I. G., Donnem, T., Bremnes, R. M., Busund, L. T.
Publicado 2019